ExLibris header image
SFX Logo
Title: A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Burns, R S yr:1983


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. HEIKKILA, R E E. "PROTECTION AGAINST THE DOPAMINERGIC NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE BY MONOAMINE-OXIDASE INHIBITORS." Nature 311.5985 (1984): 467-469. Link to Full Text for this item Link to SFX for this item
2. Lees, A J J. "Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases." Journal of neurology, neurosurgery and psychiatry 55.3 (1992): 181-184. Link to Full Text for this item Link to SFX for this item
3. Lees, A J J. "Ageing and Parkinson's disease: substantia nigra regional selectivity." Brain 114.5 (1991): 2283-301. Link to Full Text for this item Link to SFX for this item
4. Study Group, Parkinson, S. "Levodopa and the Progression of Parkinson's Disease." The New England journal of medicine 351.24 (2004): 2498-508. Link to SFX for this item
5. Goulet, B K K. "D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys." The Journal of pharmacology and experimental therapeutics 292.2 (2000): 714-24. Link to SFX for this item
6. Hughes, Andrew J J. "The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service." Brain 125.4 (2002): 861-870. Link to SFX for this item
7. Poewe, W. "The diagnosis of Parkinson's disease." Lancet. Neurology 5.1 (2005): 75-86. Link to SFX for this item
8. Rascol, O.. "A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa." New England Journal of Medicine, The 342.20 (2000): 1484-1491. Link to SFX for this item
9. Kojima, S. "Elevation of antioxidant potency in the brain of mice by low-dose gamma-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage." Free radical biology & medicine 26.3-4 (1999): 388-395. Link to Full Text for this item Link to SFX for this item
10. Gibb, W R R. "The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease." Journal of neurology, neurosurgery and psychiatry 51.6 (1988): 745-52. Link to Full Text for this item Link to SFX for this item
11. Agid, Peter W. "Levodopa in the treatment of Parkinson's disease: current controversies." Movement disorders 19.9 (2004): 997-1005. Link to Full Text for this item Link to SFX for this item
12. de Lau, Lonneke M L M. "Epidemiology of Parkinson's disease." Lancet. Neurology 5.6 (2006): 525-35. Link to SFX for this item
13. Durif, F. "Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study." Movement disorders 19.9 (2004): 1006-1011. Link to Full Text for this item Link to SFX for this item
14. Meara, J. "Accuracy of diagnosis in patients with presumed Parkinson's disease." Age and ageing 28.2: 99-102. Link to SFX for this item
15. Calne, D B B. "Aetiology of Parkinson's disease." Lancet, The 2.8365-66 (1983): 1457-9. Link to SFX for this item
16. Matzuk, Martin M. "Preservation of hypothalamic dopaminergic neurons in Parkinson's disease." Annals of neurology 18.5 (1985): 552-555. Link to Full Text for this item Link to SFX for this item
17. Damier, P. "The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry." Brain 122.8 (1999): 1421-36. Link to SFX for this item
18. Abbott, Gershon W. "Frequency of bowel movements and the future risk of Parkinson's disease." Neurology 57.3 (2001): 456-62. Link to SFX for this item
19. Streit, Wolfgang J. "The brain's immune system." Scientific American 273.5 (1995): 54-5. Link to SFX for this item
20. Chen, C. "Monoamine oxidase: From genes to behavior." Annual review of neuroscience 22.1 (1999): 197-217. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.